$43.48
$0.00 (0.00%)
End-of-day quote: 05/18/2024
NasdaqGS:AMPH
Amphastar Pharmaceuticals Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$644.40M | $498.99M | $437.77M | $349.85M | $322.36M | $294.67M | $240.18M | $255.17M | $251.52M | $210.46M | |
| GM % | Gross Margin % |
|
54.91% | 49.87% | 45.63% | 40.97% | 40.92% | 36.31% | 37.68% | 40.83% | 30.75% | 24.35% | |
| OM | Operating Margin |
|
30.99% | 21.54% | 16.38% | 3.79% | -0.01% | -2.93% | -1.63% | 6.18% | -1.43% | -8.54% | |
| EPS | Earnings Per Share |
|
$0.00 | $3.32 | $1.97 | $1.37 | $0.64 | $0.36 | $0.21 | $0.38 | $0.49 | $0.06 | $-0.12 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
48.07m | 48.11m | 47.71m | 47.5m | 46.58m | 46.63m | 46.62m | 46.25m | 45.2m | 44.65m | |
| OCF | Operating Cash Flow |
|
$183.50M | $89.18M | $97.99M | $57.27M | $41.76M | $38.19M | $39.21M | $38.56M | $10.68M | $21.05M | |
| FCF | Free Cash Flow |
|
$145.33M | $65.15M | $70.53M | $23.41M | $0.21M | $-8.62M | $4.11M | $17.18M | $-5.37M | $0.55M | |
| FCFS | Free Cash Flow Per Share |
|
$3.01 | $1.34 | $1.48 | $0.50 | $0.00 | $-0.09 | $0.13 | $0.38 | $-0.12 | $0.01 |
